Bipolar Research - Bipolar Disorder, Symptoms, Treatment, Depression, Medication

Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.


Bipolar Research Today

Home

View Latest Issue

Information About Bipolar

Books on Bipolar

Advertising in Research Today

View Other Research Today Publications

Volume 8 (2011), Issue 3 (March)

  1. Depression symptom ratings in geriatric patients with bipolar mania.
    Int J Geriatr Psychiatry. [Abstract] [Full-text]
  2. Genome-wide survey implicates the influence of copy number variants (CNVs) in the development of early-onset bipolar disorder.
    Mol Psychiatry. [Abstract] [Full-text]
  3. Prevalence of bipolar disorder in children and adolescents with attention-deficit hyperactivity disorder.
    Br J Psychiatry, 198: 195-8. [Abstract] [Full-text]
  4. Will the child with mania please stand up?
    Br J Psychiatry, 198: 171-2. [Abstract] [Full-text]
  5. 'It's something that I manage but it is not who I am': reflections on internalized stigma in individuals with bipolar disorder.
    Chronic Illn. [Abstract] [Full-text]
  6. Antidepressant-like responses to lithium in genetically diverse mouse strains.
    Genes Brain Behav. [Abstract] [Full-text]
  7. Electroconvulsive therapy for psychotropic-refractory bipolar affective disorder and severe self-injury and aggression in an 11-year-old autistic boy.
    Eur Child Adolesc Psychiatry, 20(3): 147-52. [Abstract] [Full-text]
  8. Follow-up of subjects with suspected pre-psychotic state in Taiwan.
    Schizophr Res, 126(1): 65-70. [Abstract] [Full-text]
  9. Executive functioning correctly classified diagnoses in patients with first-episode psychosis: Evidence from a 2-year longitudinal study.
    Schizophr Res, 126(1): 77-80. [Abstract] [Full-text]
  10. Effects of cannabis use on age at onset in schizophrenia and bipolar disorder.
    Schizophr Res, 126(1): 270-6. [Abstract] [Full-text]
  11. Event-related Potential Study of the Effects of Emotional Facial Expressions on Task Performance in Euthymic Bipolar Patients.
    Appl Psychophysiol Biofeedback, 36(1): 1-13. [Abstract] [Full-text]
  12. Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder.
    Eur Arch Psychiatry Clin Neurosci, 261(2): 139-43. [Abstract] [Full-text]
  13. Depression symptom ratings in geriatric patients with bipolar mania.
    Int J Geriatr Psychiatry. [Abstract] [Full-text]
  14. Genome-wide survey implicates the influence of copy number variants (CNVs) in the development of early-onset bipolar disorder.
    Mol Psychiatry. [Abstract] [Full-text]
  15. Prevalence of bipolar disorder in children and adolescents with attention-deficit hyperactivity disorder.
    Br J Psychiatry, 198: 195-8. [Abstract] [Full-text]
  16. Will the child with mania please stand up?
    Br J Psychiatry, 198: 171-2. [Abstract] [Full-text]
  17. 'It's something that I manage but it is not who I am': reflections on internalized stigma in individuals with bipolar disorder.
    Chronic Illn. [Abstract] [Full-text]
  18. Electroconvulsive therapy for psychotropic-refractory bipolar affective disorder and severe self-injury and aggression in an 11-year-old autistic boy.
    Eur Child Adolesc Psychiatry, 20(3): 147-52. [Abstract] [Full-text]
  19. Follow-up of subjects with suspected pre-psychotic state in Taiwan.
    Schizophr Res, 126(1): 65-70. [Abstract] [Full-text]
  20. Executive functioning correctly classified diagnoses in patients with first-episode psychosis: Evidence from a 2-year longitudinal study.
    Schizophr Res, 126(1): 77-80. [Abstract] [Full-text]
  21. Effects of cannabis use on age at onset in schizophrenia and bipolar disorder.
    Schizophr Res, 126(1): 270-6. [Abstract] [Full-text]
  22. Event-related Potential Study of the Effects of Emotional Facial Expressions on Task Performance in Euthymic Bipolar Patients.
    Appl Psychophysiol Biofeedback, 36(1): 1-13. [Abstract] [Full-text]
  23. Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder.
    Eur Arch Psychiatry Clin Neurosci, 261(2): 139-43. [Abstract] [Full-text]
  24. Bipolar Medication Use and Adherence to Antiretroviral Therapy Among Patients With HIV-AIDS and Bipolar Disorder.
    Psychiatr Serv, 62(3): 313-6. [Abstract] [Full-text]
  25. Medication adherence, ethnicity, and the influence of multiple psychosocial and financial barriers.
    Adm Policy Ment Health, 38(2): 86-95. [Abstract] [Full-text]
  26. Bipolar Medication Use and Adherence to Antiretroviral Therapy Among Patients With HIV-AIDS and Bipolar Disorder.
    Psychiatr Serv, 62(3): 313-6. [Abstract] [Full-text]
  27. What can we learn from chinese randomized controlled trials? A systematic review and meta-analysis of chinese venlafaxine studies.
    J Clin Psychopharmacol, 31(2): 194-200. [Abstract] [Full-text]
  28. Medication adherence, ethnicity, and the influence of multiple psychosocial and financial barriers.
    Adm Policy Ment Health, 38(2): 86-95. [Abstract] [Full-text]
  29. What can we learn from Chinese randomized controlled trials? A systematic review and meta-analysis of Chinese venlafaxine studies.
    J Clin Psychopharmacol, 31(2): 194-200. [Abstract] [Full-text]
  30. What can we learn from Chinese randomized controlled trials? A systematic review and meta-analysis of Chinese venlafaxine studies.
    J Clin Psychopharmacol, 31(2): 194-200. [Abstract] [Full-text]
  31. Moral or religious objections to suicide may protect against suicidal behavior in bipolar disorder.
    J Clin Psychiatry. [Abstract] [Full-text]
  32. Increased systemic cortisol metabolism in patients with schizophrenia and bipolar disorder: a mechanism for increased stress vulnerability?
    J Clin Psychiatry. [Abstract] [Full-text]
  33. After GWAS: Searching for Genetic Risk for Schizophrenia and Bipolar Disorder.
    Am J Psychiatry, 168(3): 253-6. [Abstract] [Full-text]
  34. After GWAS: Searching for Genetic Risk for Schizophrenia and Bipolar Disorder.
    Am J Psychiatry, 168(3): 253-6. [Abstract] [Full-text]
  35. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases.
    Genet Epidemiol. [Abstract] [Full-text]
  36. Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials.
    Int Clin Psychopharmacol. [Abstract] [Full-text]
  37. Long-term efficacy of risperidone long-acting injectable in bipolar disorder with psychotic features: a prospective study of 3-year outcomes.
    Int Clin Psychopharmacol. [Abstract] [Full-text]
  38. A Randomized Controlled Trial of Cognitive Behavioral Group Therapy for Bipolar Disorder.
    Psychother Psychosom, 80(3): 144-150. [Abstract] [Full-text]
  39. Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients.
    J Psychiatr Res. [Abstract] [Full-text]
  40. Predictors of medication nonadherence and hospitalization in Medicaid patients with bipolar I disorder given long-acting or oral antipsychotics.
    J Med Econ. [Abstract] [Full-text]
  41. Performance-based assessment of functional skills in severe mental illness: Results of a large-scale study in China.
    J Psychiatr Res. [Abstract] [Full-text]
  42. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases.
    Genet Epidemiol. [Abstract] [Full-text]
  43. Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials.
    Int Clin Psychopharmacol. [Abstract] [Full-text]
  44. Long-term efficacy of risperidone long-acting injectable in bipolar disorder with psychotic features: a prospective study of 3-year outcomes.
    Int Clin Psychopharmacol. [Abstract] [Full-text]
  45. A Randomized Controlled Trial of Cognitive Behavioral Group Therapy for Bipolar Disorder.
    Psychother Psychosom, 80(3): 144-150. [Abstract] [Full-text]
  46. Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients.
    J Psychiatr Res. [Abstract] [Full-text]
  47. Performance-based assessment of functional skills in severe mental illness: Results of a large-scale study in China.
    J Psychiatr Res. [Abstract] [Full-text]
  48. Bariatric Surgery: 1-Year Weight Loss Outcomes in Patients with Bipolar and Other Psychiatric Disorders.
    Obes Surg. [Abstract] [Full-text]
  49. Dextromethorphan abuse masquerading as a recurrent seizure disorder.
    Pediatr Emerg Care, 27(3): 210-1. [Abstract] [Full-text]
  50. The seasonality of bipolar affective disorder: Comparison with a primary care sample using the Seasonal Pattern Assessment Questionnaire.
    J Affect Disord. [Abstract] [Full-text]
  51. Gender-specific lipid profiles in patients with bipolar disorder.
    J Psychiatr Res. [Abstract] [Full-text]
  52. The effects of DISC1 risk variants on brain activation in controls, patients with bipolar disorder and patients with schizophrenia.
    Psychiatry Res. [Abstract] [Full-text]
  53. Association between bovine casein antibody and new onset schizophrenia among US military personnel.
    Schizophr Res. [Abstract] [Full-text]
  54. A retrospective look at length of stay for pediatric psychiatric patients in an urban emergency department.
    Pediatr Emerg Care, 27(3): 170-3. [Abstract] [Full-text]
  55. Bariatric Surgery: 1-Year Weight Loss Outcomes in Patients with Bipolar and Other Psychiatric Disorders.
    Obes Surg. [Abstract] [Full-text]
  56. Dextromethorphan abuse masquerading as a recurrent seizure disorder.
    Pediatr Emerg Care, 27(3): 210-1. [Abstract] [Full-text]
  57. The seasonality of bipolar affective disorder: Comparison with a primary care sample using the Seasonal Pattern Assessment Questionnaire.
    J Affect Disord. [Abstract] [Full-text]
  58. Gender-specific lipid profiles in patients with bipolar disorder.
    J Psychiatr Res. [Abstract] [Full-text]
  59. Association between bovine casein antibody and new onset schizophrenia among US military personnel.
    Schizophr Res. [Abstract] [Full-text]
  60. A retrospective look at length of stay for pediatric psychiatric patients in an urban emergency department.
    Pediatr Emerg Care, 27(3): 170-3. [Abstract] [Full-text]
  61. Tamoxifen effects on respiratory chain complexes and creatine kinase activities in an animal model of mania.
    Pharmacol Biochem Behav, 98(2): 304-10. [Abstract] [Full-text]
  62. Reproduction among 1975 Sardinian women and men diagnosed with major mood disorders.
    Acta Psychiatr Scand, 123(4): 283-9. [Abstract] [Full-text]
  63. Bariatric Surgery: 1-Year Weight Loss Outcomes in Patients with Bipolar and Other Psychiatric Disorders.
    Obes Surg. [Abstract] [Full-text]
  64. Tamoxifen effects on respiratory chain complexes and creatine kinase activities in an animal model of mania.
    Pharmacol Biochem Behav, 98(2): 304-10. [Abstract] [Full-text]
  65. Reproduction among 1975 Sardinian women and men diagnosed with major mood disorders.
    Acta Psychiatr Scand, 123(4): 283-9. [Abstract] [Full-text]
  66. Tamoxifen effects on respiratory chain complexes and creatine kinase activities in an animal model of mania.
    Pharmacol Biochem Behav, 98(2): 304-10. [Abstract] [Full-text]
  67. Reproduction among 1975 Sardinian women and men diagnosed with major mood disorders.
    Acta Psychiatr Scand, 123(4): 283-9. [Abstract] [Full-text]
  68. Treatment of HIV in Outpatients with Schizophrenia, Schizoaffective Disorder and Bipolar Disease at Two County Clinics.
    Community Ment Health J. [Abstract] [Full-text]
  69. Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling.
    Pharmacogenomics J. [Abstract] [Full-text]
  70. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative.
    Arch Gen Psychiatry, 68(3): 241-51. [Abstract] [Full-text]
  71. Common Variants in the BCL9 Gene Conferring Risk of Schizophrenia.
    Arch Gen Psychiatry, 68(3): 232-40. [Abstract] [Full-text]
  72. Mapping Corpus Callosum Morphology in Twin Pairs Discordant for Bipolar Disorder.
    Cereb Cortex. [Abstract] [Full-text]
  73. Genome-wide association study of personality traits in bipolar patients.
    Psychiatr Genet. [Abstract] [Full-text]
  74. Do risk factors for schizophrenia predispose to emigration?
    Schizophr Res, 127(1): 229-34. [Abstract] [Full-text]
  75. Treatment of HIV in Outpatients with Schizophrenia, Schizoaffective Disorder and Bipolar Disease at Two County Clinics.
    Community Ment Health J. [Abstract] [Full-text]
  76. Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling.
    Pharmacogenomics J. [Abstract] [Full-text]
  77. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative.
    Arch Gen Psychiatry, 68(3): 241-51. [Abstract] [Full-text]
  78. Common Variants in the BCL9 Gene Conferring Risk of Schizophrenia.
    Arch Gen Psychiatry, 68(3): 232-40. [Abstract] [Full-text]
  79. Mapping Corpus Callosum Morphology in Twin Pairs Discordant for Bipolar Disorder.
    Cereb Cortex. [Abstract] [Full-text]
  80. Genome-wide association study of personality traits in bipolar patients.
    Psychiatr Genet. [Abstract] [Full-text]
  81. Life stress and kindling in bipolar disorder: Review of the evidence and integration with emerging biopsychosocial theories.
    Clin Psychol Rev, 31(3): 383-98. [Abstract] [Full-text]
  82. Do risk factors for schizophrenia predispose to emigration?
    Schizophr Res, 127(1): 229-34. [Abstract] [Full-text]
  83. Atypical antipsychotic medications in the management of disruptive behaviors in children: Safety guidelines and recommendations.
    Clin Psychol Rev, 31(3): 465-71. [Abstract] [Full-text]
  84. Treatment of HIV in Outpatients with Schizophrenia, Schizoaffective Disorder and Bipolar Disease at Two County Clinics.
    Community Ment Health J. [Abstract] [Full-text]
  85. Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling.
    Pharmacogenomics J. [Abstract] [Full-text]
  86. Mapping Corpus Callosum Morphology in Twin Pairs Discordant for Bipolar Disorder.
    Cereb Cortex. [Abstract] [Full-text]
  87. Life stress and kindling in bipolar disorder: review of the evidence and integration with emerging biopsychosocial theories.
    Clin Psychol Rev, 31(3): 383-98. [Abstract] [Full-text]
  88. Do risk factors for schizophrenia predispose to emigration?
    Schizophr Res, 127(1): 229-34. [Abstract] [Full-text]
  89. Atypical antipsychotic medications in the management of disruptive behaviors in children: safety guidelines and recommendations.
    Clin Psychol Rev, 31(3): 465-71. [Abstract] [Full-text]
  90. Life stress and kindling in bipolar disorder: review of the evidence and integration with emerging biopsychosocial theories.
    Clin Psychol Rev, 31(3): 383-98. [Abstract] [Full-text]
  91. Do risk factors for schizophrenia predispose to emigration?
    Schizophr Res, 127(1): 229-34. [Abstract] [Full-text]
  92. Atypical antipsychotic medications in the management of disruptive behaviors in children: safety guidelines and recommendations.
    Clin Psychol Rev, 31(3): 465-71. [Abstract] [Full-text]
  93. Risk of osteoporosis and fracture incidence in patients on antipsychotic medication.
    Expert Opin Drug Saf. [Abstract] [Full-text]
  94. Effect of D-amino acid oxidase activator (DAOA; G72) on brain function during verbal fluency.
    Hum Brain Mapp. [Abstract] [Full-text]
  95. A meta-analysis of neuropsychological functioning in patients with early onset schizophrenia and pediatric bipolar disorder.
    J Clin Child Adolesc Psychol, 40(2): 266-80. [Abstract] [Full-text]
  96. Ratings of Patient-Provider Communication Among Veterans: Serious Mental Illnesses, Substance Use Disorders, and the Moderating Role of Trust.
    Health Commun. [Abstract] [Full-text]
  97. Fronto-limbic dysfunction in mania pre-treatment and persistent amygdala over-activity post-treatment in pediatric bipolar disorder.
    Psychopharmacology (Berl). [Abstract] [Full-text]
  98. AKT Kinase Activity Is Required for Lithium to Modulate Mood-Related Behaviors in Mice.
    Neuropsychopharmacology. [Abstract] [Full-text]
  99. Ziprasidone for maintenance treatment of bipolar I disorder in adults.
    Expert Opin Pharmacother, 12(5): 817-24. [Abstract] [Full-text]
  100. Effect of D-amino acid oxidase activator (DAOA; G72) on brain function during verbal fluency.
    Hum Brain Mapp. [Abstract] [Full-text]
  101. A meta-analysis of neuropsychological functioning in patients with early onset schizophrenia and pediatric bipolar disorder.
    J Clin Child Adolesc Psychol, 40(2): 266-80. [Abstract] [Full-text]
  102. Ratings of Patient-Provider Communication Among Veterans: Serious Mental Illnesses, Substance Use Disorders, and the Moderating Role of Trust.
    Health Commun. [Abstract] [Full-text]
  103. Fronto-limbic dysfunction in mania pre-treatment and persistent amygdala over-activity post-treatment in pediatric bipolar disorder.
    Psychopharmacology (Berl). [Abstract] [Full-text]
  104. AKT Kinase Activity Is Required for Lithium to Modulate Mood-Related Behaviors in Mice.
    Neuropsychopharmacology. [Abstract] [Full-text]
  105. Ziprasidone for maintenance treatment of bipolar I disorder in adults.
    Expert Opin Pharmacother, 12(5): 817-24. [Abstract] [Full-text]
  106. Effect of D-amino acid oxidase activator (DAOA; G72) on brain function during verbal fluency.
    Hum Brain Mapp. [Abstract] [Full-text]
  107. Fronto-limbic dysfunction in mania pre-treatment and persistent amygdala over-activity post-treatment in pediatric bipolar disorder.
    Psychopharmacology (Berl). [Abstract] [Full-text]
  108. AKT Kinase Activity Is Required for Lithium to Modulate Mood-Related Behaviors in Mice.
    Neuropsychopharmacology. [Abstract] [Full-text]
  109. Ziprasidone for maintenance treatment of bipolar I disorder in adults.
    Expert Opin Pharmacother, 12(5): 817-24. [Abstract] [Full-text]
  110. Ziprasidone for maintenance treatment of bipolar I disorder in adults.
    Expert Opin Pharmacother, 12(5): 817-24. [Abstract] [Full-text]
  111. Longitudinal analysis of cognitive performances and structural brain changes in late-life bipolar disorder.
    Int J Geriatr Psychiatry. [Abstract] [Full-text]
  112. Stressful life events predict delayed functional recovery following treatment for mania in bipolar disorder.
    Psychiatry Res, 186(2): 267-71. [Abstract] [Full-text]
  113. Longitudinal analysis of cognitive performances and structural brain changes in late-life bipolar disorder.
    Int J Geriatr Psychiatry. [Abstract] [Full-text]
  114. 2-year course of bipolar disorder type I patients in outpatient care: Factors associated with remission and functional recovery.
    Eur Neuropsychopharmacol, 21(4): 287-293. [Abstract] [Full-text]
  115. Stressful life events predict delayed functional recovery following treatment for mania in bipolar disorder.
    Psychiatry Res, 186(2): 267-71. [Abstract] [Full-text]
  116. Longitudinal analysis of cognitive performances and structural brain changes in late-life bipolar disorder.
    Int J Geriatr Psychiatry. [Abstract] [Full-text]
  117. 2-year course of bipolar disorder type I patients in outpatient care: Factors associated with remission and functional recovery.
    Eur Neuropsychopharmacol, 21(4): 287-293. [Abstract] [Full-text]
  118. 2-year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery.
    Eur Neuropsychopharmacol, 21(4): 287-93. [Abstract] [Full-text]
  119. Stressful life events predict delayed functional recovery following treatment for mania in bipolar disorder.
    Psychiatry Res, 186(2): 267-71. [Abstract] [Full-text]
  120. Neuropsychological functioning in adult bipolar disorder and ADHD patients: a comparative study.
    Psychiatry Res, 186(2): 261-6. [Abstract] [Full-text]
  121. Prevalence, correlates, and comorbidities of adult ADHD symptoms in Korea: results of the Korean epidemiologic catchment area study.
    Psychiatry Res, 186(2): 378-83. [Abstract] [Full-text]
  122. Bipolar disorder co-morbidity in children with attention deficit hyperactivity disorder.
    Psychiatry Res, 186(2): 333-7. [Abstract] [Full-text]
  123. Factors associated with work, social life and family life disability in bipolar disorder patients.
    Psychiatry Res, 186(2): 254-60. [Abstract] [Full-text]
  124. Stressful life events predict delayed functional recovery following treatment for mania in bipolar disorder.
    Psychiatry Res, 186(2): 267-71. [Abstract] [Full-text]
  125. Neuropsychological functioning in adult bipolar disorder and ADHD patients: a comparative study.
    Psychiatry Res, 186(2): 261-6. [Abstract] [Full-text]
  126. Prevalence, correlates, and comorbidities of adult ADHD symptoms in Korea: results of the Korean epidemiologic catchment area study.
    Psychiatry Res, 186(2): 378-83. [Abstract] [Full-text]
  127. Bipolar disorder co-morbidity in children with attention deficit hyperactivity disorder.
    Psychiatry Res, 186(2): 333-7. [Abstract] [Full-text]
  128. Factors associated with work, social life and family life disability in bipolar disorder patients.
    Psychiatry Res, 186(2): 254-60. [Abstract] [Full-text]
  129. Association of the C(-1019)G 5-HT1A promoter polymorphism with exposure to stressors preceding hospitalization for bipolar depression.
    J Affect Disord. [Abstract] [Full-text]
  130. Behavioral and pharmacological assessment of a potential new mouse model for mania.
    Physiol Behav. [Abstract] [Full-text]
  131. Recurrence of bipolar mania is associated with catechol-O-methyltransferase Val(108/158)Met polymorphism.
    J Affect Disord. [Abstract] [Full-text]
  132. Perturbation in Mitochondrial Network Dynamics and in Complex I Dependent Cellular Respiration in Schizophrenia.
    Biol Psychiatry. [Abstract] [Full-text]
  133. MEK/ERKs Signaling is Essential for Lithium-induced Neurite Outgrowth in N2a Cells.
    Int J Dev Neurosci. [Abstract] [Full-text]
  134. Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.
    Psychiatry Res. [Abstract] [Full-text]
  135. Examining the validity of cyclothymic disorder in a youth sample.
    J Affect Disord. [Abstract] [Full-text]
  136. Validation of a specific measure to assess health-related quality of life in patients with schizophrenia and bipolar disorder: the 'Tolerability and quality of life' (TOOL) questionnaire.
    Ann Gen Psychiatry, 10(1): 6. [Abstract] [Full-text]
  137. No Association Between Bipolar Disorder Risk Polymorphisms in ANK3 and CACNA1C and Common Migraine.
    Headache. [Abstract] [Full-text]
  138. Estimating Missing Heritability for Disease from Genome-wide Association Studies.
    Am J Hum Genet, 88(3): 294-305. [Abstract] [Full-text]
  139. Differential pattern of semantic memory organization between bipolar I and II disorders.
    Prog Neuropsychopharmacol Biol Psychiatry. [Abstract] [Full-text]
  140. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: A preliminary 4-week study.
    Neurosci Lett. [Abstract] [Full-text]
  141. Genome-wide Association Study Identifies Genetic Variation in Neurocan as a Susceptibility Factor for Bipolar Disorder.
    Am J Hum Genet, 88(3): 372-81. [Abstract] [Full-text]
  142. Mitochondria, oligodendrocytes and inflammation in bipolar disorder: Evidence from transcriptome studies points to intriguing parallels with multiple sclerosis.
    Neurobiol Dis. [Abstract] [Full-text]
  143. Association of the C(-1019)G 5-HT1A promoter polymorphism with exposure to stressors preceding hospitalization for bipolar depression.
    J Affect Disord. [Abstract] [Full-text]
  144. Recurrence of bipolar mania is associated with catechol-O-methyltransferase Val(108/158)Met polymorphism.
    J Affect Disord. [Abstract] [Full-text]
  145. Perturbation in Mitochondrial Network Dynamics and in Complex I Dependent Cellular Respiration in Schizophrenia.
    Biol Psychiatry. [Abstract] [Full-text]
  146. Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.
    Psychiatry Res. [Abstract] [Full-text]
  147. Examining the validity of cyclothymic disorder in a youth sample.
    J Affect Disord. [Abstract] [Full-text]
  148. No Association Between Bipolar Disorder Risk Polymorphisms in ANK3 and CACNA1C and Common Migraine.
    Headache. [Abstract] [Full-text]
  149. Estimating Missing Heritability for Disease from Genome-wide Association Studies.
    Am J Hum Genet, 88(3): 294-305. [Abstract] [Full-text]
  150. Genome-wide Association Study Identifies Genetic Variation in Neurocan as a Susceptibility Factor for Bipolar Disorder.
    Am J Hum Genet, 88(3): 372-81. [Abstract] [Full-text]
  151. Association of the C(-1019)G 5-HT1A promoter polymorphism with exposure to stressors preceding hospitalization for bipolar depression.
    J Affect Disord. [Abstract] [Full-text]
  152. Recurrence of bipolar mania is associated with catechol-O-methyltransferase Val(108/158)Met polymorphism.
    J Affect Disord. [Abstract] [Full-text]
  153. Perturbation in Mitochondrial Network Dynamics and in Complex I Dependent Cellular Respiration in Schizophrenia.
    Biol Psychiatry. [Abstract] [Full-text]
  154. Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.
    Psychiatry Res. [Abstract] [Full-text]
  155. Examining the validity of cyclothymic disorder in a youth sample.
    J Affect Disord. [Abstract] [Full-text]
  156. No Association Between Bipolar Disorder Risk Polymorphisms in ANK3 and CACNA1C and Common Migraine.
    Headache. [Abstract] [Full-text]
  157. Estimating Missing Heritability for Disease from Genome-wide Association Studies.
    Am J Hum Genet, 88(3): 294-305. [Abstract] [Full-text]
  158. Genome-wide Association Study Identifies Genetic Variation in Neurocan as a Susceptibility Factor for Bipolar Disorder.
    Am J Hum Genet, 88(3): 372-81. [Abstract] [Full-text]
  159. Validity of the Chinese version Mood Disorder Questionnaire (MDQ) and the optimal cutoff screening bipolar disorders.
    Psychiatry Res. [Abstract] [Full-text]
  160. Survey of the effect of genetic variations on gene expression in human prefrontal cortex and its application to genetics of psychiatric disorders.
    Neurosci Res. [Abstract] [Full-text]
  161. Validity of the Chinese version Mood Disorder Questionnaire (MDQ) and the optimal cutoff screening bipolar disorders.
    Psychiatry Res. [Abstract] [Full-text]
  162. Treatment strategies for dosing the second generation antipsychotics.
    CNS Neurosci Ther, 17(2): 110-7. [Abstract] [Full-text]
  163. Survey of the effect of genetic variations on gene expression in human prefrontal cortex and its application to genetics of psychiatric disorders.
    Neurosci Res. [Abstract] [Full-text]
  164. Validity of the Chinese version Mood Disorder Questionnaire (MDQ) and the optimal cutoff screening bipolar disorders.
    Psychiatry Res. [Abstract] [Full-text]
  165. Treatment strategies for dosing the second generation antipsychotics.
    CNS Neurosci Ther, 17(2): 110-7. [Abstract] [Full-text]
  166. Treatment strategies for dosing the second generation antipsychotics.
    CNS Neurosci Ther, 17(2): 110-7. [Abstract] [Full-text]
  167. Are screening scales for bipolar disorder good enough to be used in clinical practice?
    Compr Psychiatry. [Abstract] [Full-text]
  168. Behavioral Health Interventions Being Implemented in a VA Primary Care System.
    J Clin Psychol Med Settings, 18(1): 22-9. [Abstract] [Full-text]
  169. Are screening scales for bipolar disorder good enough to be used in clinical practice?
    Compr Psychiatry. [Abstract] [Full-text]
  170. Are Patients With Serious Mental Illness More Likely to be Admitted to Nursing Homes With More Deficiencies in Care?
    Med Care, 49(4): 397-405. [Abstract] [Full-text]
  171. Behavioral Health Interventions Being Implemented in a VA Primary Care System.
    J Clin Psychol Med Settings, 18(1): 22-9. [Abstract] [Full-text]
  172. Intimate partner violence victimization and perpetration by puerto rican women with severe mental illnesses.
    Community Ment Health J, 47(2): 156-63. [Abstract] [Full-text]
  173. Are screening scales for bipolar disorder good enough to be used in clinical practice?
    Compr Psychiatry. [Abstract] [Full-text]
  174. Are Patients With Serious Mental Illness More Likely to be Admitted to Nursing Homes With More Deficiencies in Care?
    Med Care, 49(4): 397-405. [Abstract] [Full-text]
  175. Intimate partner violence victimization and perpetration by puerto rican women with severe mental illnesses.
    Community Ment Health J, 47(2): 156-63. [Abstract] [Full-text]
  176. Are patients with serious mental illness more likely to be admitted to nursing homes with more deficiencies in care?
    Med Care, 49(4): 397-405. [Abstract] [Full-text]
  177. Intimate partner violence victimization and perpetration by Puerto Rican women with severe mental illnesses.
    Community Ment Health J, 47(2): 156-63. [Abstract] [Full-text]
  178. The comorbidity of anxiety disorders in bipolar I and bipolar II patients among Turkish population.
    J Anxiety Disord. [Abstract] [Full-text]
  179. The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.
    Br J Pharmacol. [Abstract] [Full-text]
  180. The comorbidity of anxiety disorders in bipolar I and bipolar II patients among Turkish population.
    J Anxiety Disord. [Abstract] [Full-text]
  181. The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.
    Br J Pharmacol. [Abstract] [Full-text]
  182. The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.
    Br J Pharmacol. [Abstract] [Full-text]
  183. Depression across mood disorders: review and analysis in a clinical sample.
    Compr Psychiatry. [Abstract] [Full-text]
  184. Familial and disease specific abnormalities in the neural correlates of the Stroop Task in Bipolar Disorder.
    Neuroimage. [Abstract] [Full-text]
  185. Depression across mood disorders: review and analysis in a clinical sample.
    Compr Psychiatry. [Abstract] [Full-text]
  186. Cognitive abilities and clinical variables in bipolar I depressed and euthymic patients and controls.
    J Psychiatr Res, 45(4): 495-504. [Abstract] [Full-text]
  187. Depression across mood disorders: review and analysis in a clinical sample.
    Compr Psychiatry. [Abstract] [Full-text]
  188. Cognitive abilities and clinical variables in bipolar I depressed and euthymic patients and controls.
    J Psychiatr Res, 45(4): 495-504. [Abstract] [Full-text]
  189. Cognitive abilities and clinical variables in bipolar I depressed and euthymic patients and controls.
    J Psychiatr Res, 45(4): 495-504. [Abstract] [Full-text]
  190. Neuroanatomical Profile of Antimaniac Effects of Histone Deacetylases Inhibitors.
    Mol Neurobiol. [Abstract] [Full-text]
  191. Menstrual Psychosis: A Bipolar Disorder with a Link to the Hypothalamus.
    Curr Psychiatry Rep. [Abstract] [Full-text]
  192. Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women.
    Obstet Gynecol, 117(4): 961-77. [Abstract] [Full-text]
  193. Increased risk-taking behaviour in dopamine transporter knockdown mice: further support for a mouse model of mania.
    J Psychopharmacol. [Abstract] [Full-text]
  194. A follow-up study of family burden in patients with bipolar affective disorder.
    Int J Soc Psychiatry. [Abstract] [Full-text]
  195. Decreased neuronal Na(+) ,K(+) -ATPase activity in Atp1a3 heterozygous mice increases susceptibility to depression-like endophenotypes by chronic variable stress.
    Genes Brain Behav. [Abstract] [Full-text]
  196. Differential pattern of semantic memory organization between bipolar I and II disorders.
    Prog Neuropsychopharmacol Biol Psychiatry. [Abstract] [Full-text]
  197. Predictors of medication nonadherence and hospitalization in Medicaid patients with bipolar I disorder given long-acting or oral antipsychotics.
    J Med Econ, 14(2): 217-26. [Abstract] [Full-text]
  198. Familial and disease specific abnormalities in the neural correlates of the Stroop Task in Bipolar Disorder.
    Neuroimage. [Abstract] [Full-text]
  199. Neuroanatomical Profile of Antimaniac Effects of Histone Deacetylases Inhibitors.
    Mol Neurobiol. [Abstract] [Full-text]
  200. Menstrual Psychosis: A Bipolar Disorder with a Link to the Hypothalamus.
    Curr Psychiatry Rep. [Abstract] [Full-text]
  201. Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women.
    Obstet Gynecol, 117(4): 961-77. [Abstract] [Full-text]
  202. Increased risk-taking behaviour in dopamine transporter knockdown mice: further support for a mouse model of mania.
    J Psychopharmacol. [Abstract] [Full-text]
  203. A follow-up study of family burden in patients with bipolar affective disorder.
    Int J Soc Psychiatry. [Abstract] [Full-text]
  204. Predictors of medication nonadherence and hospitalization in Medicaid patients with bipolar I disorder given long-acting or oral antipsychotics.
    J Med Econ, 14(2): 217-26. [Abstract] [Full-text]
  205. Neuroanatomical Profile of Antimaniac Effects of Histone Deacetylases Inhibitors.
    Mol Neurobiol. [Abstract] [Full-text]
  206. Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women.
    Obstet Gynecol, 117(4): 961-77. [Abstract] [Full-text]
  207. Was it something I did wrong? A qualitative analysis of parental perspectives of their child's bipolar disorder.
    J Psychiatr Ment Health Nurs, 18(4): 342-8. [Abstract] [Full-text]
  208. Outcomes of an educational intervention for the family of a person with bipolar disorder: a 2-year follow-up study.
    J Psychiatr Ment Health Nurs, 18(4): 333-341. [Abstract] [Full-text]
  209. Was it something I did wrong? A qualitative analysis of parental perspectives of their child's bipolar disorder.
    J Psychiatr Ment Health Nurs, 18(4): 342-8. [Abstract] [Full-text]
  210. Outcomes of an educational intervention for the family of a person with bipolar disorder: a 2-year follow-up study.
    J Psychiatr Ment Health Nurs, 18(4): 333-41. [Abstract] [Full-text]
  211. Early Response to Psychotherapy and Long-Term Change in Worry Symptoms in Older Adults With Generalized Anxiety Disorder.
    Am J Geriatr Psychiatry, 19(4): 347-356. [Abstract] [Full-text]
  212. Andrés Piquer-Arrufat (1711-1772): Contributions of an Eighteenth-Century Spanish Physician to the Concept of Manic-Depressive Illness.
    Harv Rev Psychiatry, 19(2): 68-77. [Abstract] [Full-text]
  213. The role of antipsychotics in smoking and smoking cessation.
    CNS Drugs, 25(4): 299-315. [Abstract] [Full-text]
  214. Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations.
    CNS Drugs, 25(4): 289-98. [Abstract] [Full-text]
  215. Validation of a specific measure to assess health-related quality of life in patients with schizophrenia and bipolar disorder: the 'Tolerability and quality of life' (TOOL) questionnaire.
    Ann Gen Psychiatry, 10: 6. [Abstract] [Full-text]
  216. Schizoaffective disorder: a review of current research themes and pharmacological management.
    CNS Drugs, 25(4): 317-31. [Abstract] [Full-text]
  217. Early Response to Psychotherapy and Long-Term Change in Worry Symptoms in Older Adults With Generalized Anxiety Disorder.
    Am J Geriatr Psychiatry, 19(4): 347-356. [Abstract] [Full-text]
  218. The role of antipsychotics in smoking and smoking cessation.
    CNS Drugs, 25(4): 299-315. [Abstract] [Full-text]
  219. Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations.
    CNS Drugs, 25(4): 289-98. [Abstract] [Full-text]
  220. Validation of a specific measure to assess health-related quality of life in patients with schizophrenia and bipolar disorder: the 'Tolerability and quality of life' (TOOL) questionnaire.
    Ann Gen Psychiatry, 10: 6. [Abstract] [Full-text]
  221. Schizoaffective disorder: a review of current research themes and pharmacological management.
    CNS Drugs, 25(4): 317-31. [Abstract] [Full-text]
  222. Early response to psychotherapy and long-term change in worry symptoms in older adults with generalized anxiety disorder.
    Am J Geriatr Psychiatry, 19(4): 347-56. [Abstract] [Full-text]
  223. The role of antipsychotics in smoking and smoking cessation.
    CNS Drugs, 25(4): 299-315. [Abstract] [Full-text]
  224. Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations.
    CNS Drugs, 25(4): 289-98. [Abstract] [Full-text]
  225. Schizoaffective disorder: a review of current research themes and pharmacological management.
    CNS Drugs, 25(4): 317-31. [Abstract] [Full-text]
  226. Seasonal symptoms in bipolar and primary care patients.
    J Affect Disord. [Abstract] [Full-text]
  227. Trait-Related Decision-Making Impairment in the Three Phases of Bipolar Disorder.
    Biol Psychiatry. [Abstract] [Full-text]
  228. White Matter Integrity in Individuals at High Genetic Risk of Bipolar Disorder.
    Biol Psychiatry. [Abstract] [Full-text]
  229. Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interview.
    Acta Neurol Scand. [Abstract] [Full-text]
  230. Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D(1) receptor mechanism.
    Psychopharmacology (Berl), 214(4): 843-53. [Abstract] [Full-text]
  231. Modulatory effect of cod-liver oil on Na+-K+ ATPase in rats' brain.
    Hum Exp Toxicol, 30(4): 267-74. [Abstract] [Full-text]
  232. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder.
    Mol Psychiatry, 16(4): 429-41. [Abstract] [Full-text]
  233. Genetic variation in cholinergic muscarinic-2 receptor gene modulates M(2) receptor binding in vivo and accounts for reduced binding in bipolar disorder.
    Mol Psychiatry, 16(4): 407-18. [Abstract] [Full-text]
  234. Integrative genome-wide association analysis of cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders.
    Mol Psychiatry, 16(4): 452-61. [Abstract] [Full-text]
  235. Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients.
    Mol Psychiatry, 16(4): 419-28. [Abstract] [Full-text]
  236. Seasonal symptoms in bipolar and primary care patients.
    J Affect Disord. [Abstract] [Full-text]
  237. Trait-Related Decision-Making Impairment in the Three Phases of Bipolar Disorder.
    Biol Psychiatry. [Abstract] [Full-text]
  238. White Matter Integrity in Individuals at High Genetic Risk of Bipolar Disorder.
    Biol Psychiatry. [Abstract] [Full-text]
  239. Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interview.
    Acta Neurol Scand. [Abstract] [Full-text]
  240. Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D(1) receptor mechanism.
    Psychopharmacology (Berl), 214(4): 843-53. [Abstract] [Full-text]
  241. Modulatory effect of cod-liver oil on Na+-K+ ATPase in rats' brain.
    Hum Exp Toxicol, 30(4): 267-74. [Abstract] [Full-text]
  242. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder.
    Mol Psychiatry, 16(4): 429-41. [Abstract] [Full-text]
  243. Genetic variation in cholinergic muscarinic-2 receptor gene modulates M(2) receptor binding in vivo and accounts for reduced binding in bipolar disorder.
    Mol Psychiatry, 16(4): 407-18. [Abstract] [Full-text]
  244. Integrative genome-wide association analysis of cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders.
    Mol Psychiatry, 16(4): 452-61. [Abstract] [Full-text]
  245. Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients.
    Mol Psychiatry, 16(4): 419-28. [Abstract] [Full-text]
  246. Seasonal symptoms in bipolar and primary care patients.
    J Affect Disord. [Abstract] [Full-text]
  247. Trait-Related Decision-Making Impairment in the Three Phases of Bipolar Disorder.
    Biol Psychiatry. [Abstract] [Full-text]
  248. White Matter Integrity in Individuals at High Genetic Risk of Bipolar Disorder.
    Biol Psychiatry. [Abstract] [Full-text]
  249. Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interview.
    Acta Neurol Scand. [Abstract] [Full-text]
  250. Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D(1) receptor mechanism.
    Psychopharmacology (Berl), 214(4): 843-53. [Abstract] [Full-text]
  251. Modulatory effect of cod-liver oil on Na+-K+ ATPase in rats' brain.
    Hum Exp Toxicol, 30(4): 267-74. [Abstract] [Full-text]
  252. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder.
    Mol Psychiatry, 16(4): 429-41. [Abstract] [Full-text]
  253. Genetic variation in cholinergic muscarinic-2 receptor gene modulates M(2) receptor binding in vivo and accounts for reduced binding in bipolar disorder.
    Mol Psychiatry, 16(4): 407-18. [Abstract] [Full-text]
  254. Integrative genome-wide association analysis of cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders.
    Mol Psychiatry, 16(4): 452-61. [Abstract] [Full-text]
  255. Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients.
    Mol Psychiatry, 16(4): 419-28. [Abstract] [Full-text]
  256. The association between family history of mental disorder and delusional-like experiences: A general population study.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
  257. Dysfunctional gene splicing as a potential contributor to neuropsychiatric disorders.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
  258. P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
  259. Association of ANK3 with bipolar disorder confirmed in East Asia.
    Am J Med Genet B Neuropsychiatr Genet, 156(3): 312-5. [Abstract] [Full-text]
  260. Bizarreness in dream reports and waking fantasies of psychotic schizophrenic and manic patients: Empirical evidences and theoretical consequences.
    Psychiatry Res. [Abstract] [Full-text]
  261. Symptoms and behaviors prior to the first major affective episode of bipolar II disorder. An exploratory study.
    J Affect Disord. [Abstract] [Full-text]
  262. Class effect of pharmacotherapy in bipolar disorder: fact or fiction?
    Ann Gen Psychiatry, 10(1): 8. [Abstract] [Full-text]
  263. Driven sexual behavior in bipolar spectrum patients: psychodynamic issues.
    J Am Acad Psychoanal Dyn Psychiatry, 39(1): 77-92. [Abstract] [Full-text]
  264. Behavioral and pharmacological assessment of a potential new mouse model for mania.
    Physiol Behav. [Abstract] [Full-text]
  265. Genome-wide association analysis of age at onset and psychotic symptoms in bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 156(3): 370-378. [Abstract] [Full-text]
  266. Dysbindin-1 gene contributes differentially to early- and adult-onset forms of functional psychosis.
    Am J Med Genet B Neuropsychiatr Genet, 156(3): 322-33. [Abstract] [Full-text]
  267. The association between family history of mental disorder and delusional-like experiences: A general population study.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
  268. Dysfunctional gene splicing as a potential contributor to neuropsychiatric disorders.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
  269. P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
  270. Association of ANK3 with bipolar disorder confirmed in East Asia.
    Am J Med Genet B Neuropsychiatr Genet, 156(3): 312-5. [Abstract] [Full-text]
  271. Bizarreness in dream reports and waking fantasies of psychotic schizophrenic and manic patients: Empirical evidences and theoretical consequences.
    Psychiatry Res. [Abstract] [Full-text]
  272. Symptoms and behaviors prior to the first major affective episode of bipolar II disorder. An exploratory study.
    J Affect Disord. [Abstract] [Full-text]
  273. Class effect of pharmacotherapy in bipolar disorder: fact or fiction?
    Ann Gen Psychiatry, 10(1): 8. [Abstract] [Full-text]
  274. Driven sexual behavior in bipolar spectrum patients: psychodynamic issues.
    J Am Acad Psychoanal Dyn Psychiatry, 39(1): 77-92. [Abstract] [Full-text]
  275. Genome-wide association analysis of age at onset and psychotic symptoms in bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 156(3): 370-378. [Abstract] [Full-text]
  276. Dysbindin-1 gene contributes differentially to early- and adult-onset forms of functional psychosis.
    Am J Med Genet B Neuropsychiatr Genet, 156(3): 322-33. [Abstract] [Full-text]
  277. Association of ANK3 with bipolar disorder confirmed in East Asia.
    Am J Med Genet B Neuropsychiatr Genet, 156(3): 312-5. [Abstract] [Full-text]
  278. Bizarreness in dream reports and waking fantasies of psychotic schizophrenic and manic patients: Empirical evidences and theoretical consequences.
    Psychiatry Res. [Abstract] [Full-text]
  279. Symptoms and behaviors prior to the first major affective episode of bipolar II disorder. An exploratory study.
    J Affect Disord. [Abstract] [Full-text]
  280. Driven sexual behavior in bipolar spectrum patients: psychodynamic issues.
    J Am Acad Psychoanal Dyn Psychiatry, 39(1): 77-92. [Abstract] [Full-text]
  281. Genome-wide association analysis of age at onset and psychotic symptoms in bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 156(3): 370-378. [Abstract] [Full-text]
  282. Dysbindin-1 gene contributes differentially to early- and adult-onset forms of functional psychosis.
    Am J Med Genet B Neuropsychiatr Genet, 156(3): 322-33. [Abstract] [Full-text]
  283. Sensitivity and specificity of the mood disorder questionnaire and the bipolar spectrum diagnostic scale in Argentinean patients with mood disorders.
    J Affect Disord. [Abstract] [Full-text]
  284. Knockdown of mental disorder susceptibility genes disrupts neuronal network physiology in vitro.
    Mol Cell Neurosci. [Abstract] [Full-text]
  285. Despite clinical differences, bipolar disorder patients from acute wards and outpatient clinics have similar educational and disability levels compared to the general population.
    J Affect Disord. [Abstract] [Full-text]
  286. Difference in Temperament and Character Inventory scores between depressed patients with bipolar II and unipolar major depressive disorders.
    J Affect Disord. [Abstract] [Full-text]
  287. Identifying a cognitive impairment subgroup in adults with mood disorders.
    J Affect Disord. [Abstract] [Full-text]
  288. MEK/ERKs signaling is essential for lithium-induced neurite outgrowth in N2a cells.
    Int J Dev Neurosci. [Abstract] [Full-text]
  289. Risk of osteoporosis and fracture incidence in patients on antipsychotic medication.
    Expert Opin Drug Saf. [Abstract] [Full-text]
  290. The effects of DISC1 risk variants on brain activation in controls, patients with bipolar disorder and patients with schizophrenia.
    Psychiatry Res, 192(1): 20-8. [Abstract] [Full-text]
  291. Volume reduction of ventromedial prefrontal cortex in bipolar II patients with rapid cycling: A voxel-based morphometric study.
    Prog Neuropsychopharmacol Biol Psychiatry, 35(2): 439-45. [Abstract] [Full-text]
  292. Increased breath ethane levels in medicated patients with schizophrenia and bipolar disorder are unrelated to erythrocyte omega-3 fatty acid abundance.
    Prog Neuropsychopharmacol Biol Psychiatry, 35(2): 446-53. [Abstract] [Full-text]
  293. Sensitivity and specificity of the mood disorder questionnaire and the bipolar spectrum diagnostic scale in Argentinean patients with mood disorders.
    J Affect Disord. [Abstract] [Full-text]
  294. Despite clinical differences, bipolar disorder patients from acute wards and outpatient clinics have similar educational and disability levels compared to the general population.
    J Affect Disord. [Abstract] [Full-text]
  295. Difference in Temperament and Character Inventory scores between depressed patients with bipolar II and unipolar major depressive disorders.
    J Affect Disord. [Abstract] [Full-text]
  296. Identifying a cognitive impairment subgroup in adults with mood disorders.
    J Affect Disord. [Abstract] [Full-text]
  297. MEK/ERKs signaling is essential for lithium-induced neurite outgrowth in N2a cells.
    Int J Dev Neurosci. [Abstract] [Full-text]
  298. Risk of osteoporosis and fracture incidence in patients on antipsychotic medication.
    Expert Opin Drug Saf. [Abstract] [Full-text]
  299. Volume reduction of ventromedial prefrontal cortex in bipolar II patients with rapid cycling: A voxel-based morphometric study.
    Prog Neuropsychopharmacol Biol Psychiatry, 35(2): 439-45. [Abstract] [Full-text]
  300. Increased breath ethane levels in medicated patients with schizophrenia and bipolar disorder are unrelated to erythrocyte omega-3 fatty acid abundance.
    Prog Neuropsychopharmacol Biol Psychiatry, 35(2): 446-53. [Abstract] [Full-text]
  301. Sensitivity and specificity of the mood disorder questionnaire and the bipolar spectrum diagnostic scale in Argentinean patients with mood disorders.
    J Affect Disord. [Abstract] [Full-text]
  302. Despite clinical differences, bipolar disorder patients from acute wards and outpatient clinics have similar educational and disability levels compared to the general population.
    J Affect Disord. [Abstract] [Full-text]
  303. Difference in Temperament and Character Inventory scores between depressed patients with bipolar II and unipolar major depressive disorders.
    J Affect Disord. [Abstract] [Full-text]
  304. Identifying a cognitive impairment subgroup in adults with mood disorders.
    J Affect Disord. [Abstract] [Full-text]
  305. MEK/ERKs signaling is essential for lithium-induced neurite outgrowth in N2a cells.
    Int J Dev Neurosci. [Abstract] [Full-text]
  306. The effects of DISC1 risk variants on brain activation in controls, patients with bipolar disorder and patients with schizophrenia.
    Psychiatry Res, 192(1): 20-8. [Abstract] [Full-text]
  307. Volume reduction of ventromedial prefrontal cortex in bipolar II patients with rapid cycling: A voxel-based morphometric study.
    Prog Neuropsychopharmacol Biol Psychiatry, 35(2): 439-45. [Abstract] [Full-text]
  308. Increased breath ethane levels in medicated patients with schizophrenia and bipolar disorder are unrelated to erythrocyte omega-3 fatty acid abundance.
    Prog Neuropsychopharmacol Biol Psychiatry, 35(2): 446-53. [Abstract] [Full-text]
  309. The role of mental disorders in the risk and speed of transition to alcohol use disorders among community youth.
    Psychol Med, 41(5): 1073-85. [Abstract] [Full-text]
  310. The effects of DISC1 risk variants on brain activation in controls, patients with bipolar disorder and patients with schizophrenia.
    Psychiatry Res, 192(1): 20-8. [Abstract] [Full-text]
  311. The role of mental disorders in the risk and speed of transition to alcohol use disorders among community youth.
    Psychol Med, 41(5): 1073-85. [Abstract] [Full-text]
  312. DISC1 exon 11 rare variants found more commonly in schizoaffective spectrum cases than controls.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
  313. The activation of monocyte and T cell networks in patients with bipolar disorder.
    Brain Behav Immun. [Abstract] [Full-text]
  314. Executive functioning in familial bipolar I disorder patients and their unaffected relatives.
    Bipolar Disord, 13(2): 208-16. [Abstract] [Full-text]
  315. Association between the DAOA/G72 gene and bipolar disorder and meta-analyses in bipolar disorder and schizophrenia.
    Bipolar Disord, 13(2): 198-207. [Abstract] [Full-text]
  316. Neurochemical deficits in the cerebellar vermis in child offspring of parents with bipolar disorder.
    Bipolar Disord, 13(2): 189-97. [Abstract] [Full-text]
  317. Changes in the prevalence of bipolar disorders between 1998 and 2008 in an Australian population.
    Bipolar Disord, 13(2): 182-8. [Abstract] [Full-text]
  318. Criminal conviction, impulsivity, and course of illness in bipolar disorder.
    Bipolar Disord, 13(2): 173-81. [Abstract] [Full-text]
  319. Emotional modulation of response inhibition in stable patients with bipolar I disorder: a comparison with healthy and schizophrenia subjects.
    Bipolar Disord, 13(2): 164-72. [Abstract] [Full-text]
  320. A 15-year prospective follow-up of bipolar affective disorders: comparisons with unipolar nonpsychotic depression.
    Bipolar Disord, 13(2): 155-63. [Abstract] [Full-text]
  321. Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients.
    Bipolar Disord, 13(2): 145-54. [Abstract] [Full-text]
  322. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
    Bipolar Disord, 13(2): 133-44. [Abstract] [Full-text]
  323. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
    Brain Behav Immun. [Abstract] [Full-text]
  324. Shared impairment in associative learning in schizophrenia and bipolar disorder.
    Prog Neuropsychopharmacol Biol Psychiatry. [Abstract] [Full-text]
  325. Sex-specific cortisol levels in bipolar disorder and schizophrenia during mental challenge - Relationship to clinical characteristics and medication.
    Prog Neuropsychopharmacol Biol Psychiatry. [Abstract] [Full-text]
  326. DISC1 exon 11 rare variants found more commonly in schizoaffective spectrum cases than controls.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
  327. Relationship between cognitive functioning and 6-month clinical and functional outcome in patients with first manic episode bipolar I disorder.
    Psychol Med, 41(5): 971-82. [Abstract] [Full-text]
  328. Relationship between cognitive functioning and 6-month clinical and functional outcome in patients with first manic episode bipolar I disorder.
    Psychol Med, 41(5): 971-82. [Abstract] [Full-text]
  329. Role of COMT, 5-HT(1A) , and SERT genetic polymorphisms on antidepressant response to transcranial magnetic stimulation.
    Depress Anxiety. [Abstract] [Full-text]
  330. Group psychosocial interventions for adults with schizophrenia and bipolar illness: The evidence base in the light of publications between 1986 and 2006.
    Int J Soc Psychiatry. [Abstract] [Full-text]
  331. Bipolar disorder and dementia: where is the link?
    Psychogeriatrics, 11(1): 60-7. [Abstract] [Full-text]
  332. Update on Newer Antipsychotic Drugs.
    J Psychosoc Nurs Ment Health Serv. [Abstract] [Full-text]
  333. Differential effects of DAAO on regional activation and functional connectivity in schizophrenia, bipolar disorder and controls.
    Neuroimage. [Abstract] [Full-text]
  334. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: A preliminary 4-week study.
    Neurosci Lett, 494(1): 54-6. [Abstract] [Full-text]
  335. Is the lack of association between cognitive complaints and objective cognitive functioning in patients with bipolar disorder moderated by depressive symptoms?
    J Affect Disord, 130(1): 306-11. [Abstract] [Full-text]
  336. Cognitive functions among euthymic bipolar I patients after a single manic episode versus recurrent episodes.
    J Affect Disord, 130(1): 180-91. [Abstract] [Full-text]
  337. Patterns of Axis I comorbidity in relation to age in patients with Bipolar Disorder: A cross-sectional analysis.
    J Affect Disord, 130(1): 318-22. [Abstract] [Full-text]
  338. Clinical correlates of eating disorder comorbidity in women with bipolar disorder type I.
    J Affect Disord, 130(1): 162-5. [Abstract] [Full-text]
  339. Childhood CBCL bipolar profile and adolescent/young adult personality disorders: A 9-year follow-up.
    J Affect Disord, 130(1): 155-61. [Abstract] [Full-text]
  340. Stigma and functioning in patients with bipolar disorder.
    J Affect Disord, 130(1): 323-327. [Abstract] [Full-text]
  341. Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts.
    J Affect Disord, 130(1): 220-5. [Abstract] [Full-text]
  342. Cross-sectional and longitudinal relations between affective instability and depression.
    J Affect Disord, 130(1): 53-9. [Abstract] [Full-text]
  343. Role of COMT, 5-HT(1A) , and SERT genetic polymorphisms on antidepressant response to transcranial magnetic stimulation.
    Depress Anxiety. [Abstract] [Full-text]
  344. Group psychosocial interventions for adults with schizophrenia and bipolar illness: The evidence base in the light of publications between 1986 and 2006.
    Int J Soc Psychiatry. [Abstract] [Full-text]
  345. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: A preliminary 4-week study.
    Neurosci Lett, 494(1): 54-6. [Abstract] [Full-text]
  346. Is the lack of association between cognitive complaints and objective cognitive functioning in patients with bipolar disorder moderated by depressive symptoms?
    J Affect Disord, 130(1): 306-11. [Abstract] [Full-text]
  347. Cognitive functions among euthymic bipolar I patients after a single manic episode versus recurrent episodes.
    J Affect Disord, 130(1): 180-91. [Abstract] [Full-text]
  348. Patterns of Axis I comorbidity in relation to age in patients with Bipolar Disorder: A cross-sectional analysis.
    J Affect Disord, 130(1): 318-22. [Abstract] [Full-text]
  349. Clinical correlates of eating disorder comorbidity in women with bipolar disorder type I.
    J Affect Disord, 130(1): 162-5. [Abstract] [Full-text]
  350. Childhood CBCL bipolar profile and adolescent/young adult personality disorders: A 9-year follow-up.
    J Affect Disord, 130(1): 155-61. [Abstract] [Full-text]
  351. Stigma and functioning in patients with bipolar disorder.
    J Affect Disord, 130(1): 323-327. [Abstract] [Full-text]
  352. Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts.
    J Affect Disord, 130(1): 220-5. [Abstract] [Full-text]
  353. Cross-sectional and longitudinal relations between affective instability and depression.
    J Affect Disord, 130(1): 53-9. [Abstract] [Full-text]
  354. Role of COMT, 5-HT(1A) , and SERT genetic polymorphisms on antidepressant response to transcranial magnetic stimulation.
    Depress Anxiety. [Abstract] [Full-text]
  355. Group psychosocial interventions for adults with schizophrenia and bipolar illness: The evidence base in the light of publications between 1986 and 2006.
    Int J Soc Psychiatry. [Abstract] [Full-text]
  356. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: A preliminary 4-week study.
    Neurosci Lett, 494(1): 54-6. [Abstract] [Full-text]
  357. Is the lack of association between cognitive complaints and objective cognitive functioning in patients with bipolar disorder moderated by depressive symptoms?
    J Affect Disord, 130(1): 306-11. [Abstract] [Full-text]
  358. Cognitive functions among euthymic bipolar I patients after a single manic episode versus recurrent episodes.
    J Affect Disord, 130(1): 180-91. [Abstract] [Full-text]
  359. Patterns of Axis I comorbidity in relation to age in patients with Bipolar Disorder: A cross-sectional analysis.
    J Affect Disord, 130(1): 318-22. [Abstract] [Full-text]
  360. Clinical correlates of eating disorder comorbidity in women with bipolar disorder type I.
    J Affect Disord, 130(1): 162-5. [Abstract] [Full-text]
  361. Childhood CBCL bipolar profile and adolescent/young adult personality disorders: A 9-year follow-up.
    J Affect Disord, 130(1): 155-61. [Abstract] [Full-text]
  362. Stigma and functioning in patients with bipolar disorder.
    J Affect Disord, 130(1): 323-327. [Abstract] [Full-text]
  363. Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts.
    J Affect Disord, 130(1): 220-5. [Abstract] [Full-text]
  364. Cross-sectional and longitudinal relations between affective instability and depression.
    J Affect Disord, 130(1): 53-9. [Abstract] [Full-text]
  365. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study.
    Neurosci Lett, 494(1): 54-6. [Abstract] [Full-text]
  366. The MATRICS Consensus Cognitive Battery in Patients with Bipolar I Disorder.
    Neuropsychopharmacology. [Abstract] [Full-text]
  367. Adherence to guidelines by French psychiatrists in their real world of clinical practice.
    J Nerv Ment Dis, 199(4): 239-43. [Abstract] [Full-text]
  368. Co-occurring manic symptomatology influences HPA axis alterations in depression.
    J Psychiatr Res. [Abstract] [Full-text]
  369. Psychosocial functioning, familiality, and psychiatric comorbidity in bipolar youth with and without psychotic features.
    J Clin Psychiatry, 72(3): 397-405. [Abstract] [Full-text]
  370. Performance improvement CME: long-term treatment of bipolar disorder.
    J Clin Psychiatry, 72(3): e9. [Abstract] [Full-text]
  371. Pharmacotherapy for the treatment of acute bipolar II depression: current evidence.
    J Clin Psychiatry, 72(3): 356-66. [Abstract] [Full-text]
  372. The MATRICS Consensus Cognitive Battery in Patients with Bipolar I Disorder.
    Neuropsychopharmacology. [Abstract] [Full-text]
  373. Adherence to guidelines by French psychiatrists in their real world of clinical practice.
    J Nerv Ment Dis, 199(4): 239-43. [Abstract] [Full-text]
  374. Co-occurring manic symptomatology influences HPA axis alterations in depression.
    J Psychiatr Res. [Abstract] [Full-text]
  375. The MATRICS Consensus Cognitive Battery in Patients with Bipolar I Disorder.
    Neuropsychopharmacology. [Abstract] [Full-text]
  376. Adherence to guidelines by French psychiatrists in their real world of clinical practice.
    J Nerv Ment Dis, 199(4): 239-43. [Abstract] [Full-text]
  377. Co-occurring manic symptomatology influences HPA axis alterations in depression.
    J Psychiatr Res. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2004-2013 Bipolar Research Today. All Rights Reserved.

Bipolar Research Today Archive:

Volume 1 (2004)
  Issue 1 (September)
  Issue 2 (October)
  Issue 3 (November)
  Issue 4 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 9 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 10 (2013)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)



Bipolar Books

Psychology Today: Taming Bipolar Disorder (Psychology Today Here to Help)

Psychology Today: Taming Bipolar Disorder (Psychology Today Here to Help)